Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
- First Posted Date
- 2011-01-11
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Agennix
- Target Recruit Count
- 1280
- Registration Number
- NCT01273779
- Locations
- 🇺🇸
University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸Providence Hospital, Mobile, Alabama, United States
🇺🇸Maricopa Medical Center, Maricopa, Arizona, United States
Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies
- Conditions
- Hematological Malignancies
- First Posted Date
- 2010-07-23
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- Agennix
- Registration Number
- NCT01168882
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
- First Posted Date
- 2009-03-03
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Agennix
- Target Recruit Count
- 120
- Registration Number
- NCT00854633
- Locations
- 🇺🇸
Childrens Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸Kosair Children's Hospital, Louisville, Kentucky, United States
🇺🇸University of Louisville Hospital, Louisville, Kentucky, United States
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2012-08-21
- Lead Sponsor
- Agennix
- Target Recruit Count
- 742
- Registration Number
- NCT00707304
- Locations
- 🇺🇸
Desert Oasis Cancer Center, Casa Grande, Arizona, United States
🇺🇸Arizona Oncology Associates, Tucson, Arizona, United States
🇺🇸University of Colorado Hospital, Aurora, Colorado, United States
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Agennix
- Target Recruit Count
- 1100
- Registration Number
- NCT00706862
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
- Prev
- 1
- 2
- 3
- 4
- Next